Wuxi Biologics Stock Market Value
| WXIBF Stock | USD 2.50 0.64 34.41% |
| Symbol | WuXi |
WuXi Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to WuXi Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of WuXi Biologics.
| 12/22/2022 |
| 12/11/2024 |
If you would invest 0.00 in WuXi Biologics on December 22, 2022 and sell it all today you would earn a total of 0.00 from holding WuXi Biologics or generate 0.0% return on investment in WuXi Biologics over 720 days. WuXi Biologics is related to or competes with Edgewise Therapeutics, Keros Therapeutics, Monte Rosa, Mineralys Therapeutics,, Erasca, Travere Therapeutics, and Ikena Oncology. WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in... More
WuXi Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure WuXi Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess WuXi Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1469 | |||
| Maximum Drawdown | 54.59 | |||
| Potential Upside | 15.91 |
WuXi Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for WuXi Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as WuXi Biologics' standard deviation. In reality, there are many statistical measures that can use WuXi Biologics historical prices to predict the future WuXi Biologics' volatility.| Risk Adjusted Performance | 0.1274 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.0299 | |||
| Treynor Ratio | (11.81) |
WuXi Biologics Backtested Returns
WuXi Biologics is dangerous given 3 months investment horizon. WuXi Biologics shows Sharpe Ratio of 0.17, which attests that the company had a 0.17% return per unit of risk over the last 3 months. We have analyzed twenty different technical indicators, which can help you to evaluate if expected returns of 1.24% are justified by taking the suggested risk. Use WuXi Biologics Standard Deviation of 7.33, mean deviation of 3.09, and Market Risk Adjusted Performance of (11.80) to evaluate company specific risk that cannot be diversified away. WuXi Biologics holds a performance score of 13 on a scale of zero to a hundred. The firm maintains a market beta of -0.1, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning WuXi Biologics are expected to decrease at a much lower rate. During the bear market, WuXi Biologics is likely to outperform the market. Use WuXi Biologics standard deviation, skewness, price action indicator, as well as the relationship between the jensen alpha and rate of daily change , to analyze future returns on WuXi Biologics.
Auto-correlation | 0.68 |
Good predictability
WuXi Biologics has good predictability. Overlapping area represents the amount of predictability between WuXi Biologics time series from 22nd of December 2022 to 17th of December 2023 and 17th of December 2023 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of WuXi Biologics price movement. The serial correlation of 0.68 indicates that around 68.0% of current WuXi Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.51 |
WuXi Biologics lagged returns against current returns
Autocorrelation, which is WuXi Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting WuXi Biologics' pink sheet expected returns. We can calculate the autocorrelation of WuXi Biologics returns to help us make a trade decision. For example, suppose you find that WuXi Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
WuXi Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If WuXi Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if WuXi Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in WuXi Biologics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
WuXi Biologics Lagged Returns
When evaluating WuXi Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of WuXi Biologics pink sheet have on its future price. WuXi Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, WuXi Biologics autocorrelation shows the relationship between WuXi Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in WuXi Biologics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in WuXi Pink Sheet
WuXi Biologics financial ratios help investors to determine whether WuXi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WuXi with respect to the benefits of owning WuXi Biologics security.